CDMO business launch

SRN001, Receive the CSR of Australian Phase 1a clinical trial

SRN001, Registration of Japanese patent for obesity treatment composition

SRN001, Initiation of Phase 1a clinical trial for idiopathic pulmonary fibrosis (IPF)

SRN001, Registration of Japanese patent for fibrosis treatment candidate substance

2022 Seoul Innovation QuickFire Challenge Award

siRNAgen Therapeutics is founded